Genomic Evolution of Sars-Cov-2 in Molnupiravir-Treated Patients Compared to Paxlovid-Treated and Drug-Naïve Patients: A Proof-of-Concept Study

Claudia Alteri(University of Milan), Carlo Federico Perno(Centre International De Reference Chantal Biya), Giulia Burastero(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Matteo Faltoni(University of Modena and Reggio Emilia), Sara Volpi(University of Modena and Reggio Emilia), Alberto Villani(University of Milan), Valeria Fox(University of Milan), Erica Franceschini(University of Modena and Reggio Emilia), Annarita Granaglia(Bambino Gesù Children's Hospital), Marianna Meschiari(Azienda Ospedaliero-Universitaria di Modena), Rossana Scutari(Bambino Gesù Children's Hospital), Cristina Russo(Bambino Gesù Children's Hospital), Valentino Costabile(Bambino Gesù Children's Hospital), Beatrice Fontana(University of Modena and Reggio Emilia), Altea Gallerani(Azienda Ospedaliero-Universitaria di Modena), Stefania Bernardi(Bambino Gesù Children's Hospital), Cristina Mussini(University of Modena and Reggio Emilia), Sara Esperti(University of Modena and Reggio Emilia), Paola Bernaschi(Bambino Gesù Children's Hospital), Vanessa Fini(Bambino Gesù Children's Hospital), Andrea Campana(Istituti di Ricovero e Cura a Carattere Scientifico), Giovanni Guaraldi(University of Modena and Reggio Emilia)

Research Square

October 6, 2022

Cited by 4

|New England Journal of Medicine|2022|2.2k

|Clinical Infectious Diseases|2011|1.3k

|The Lancet Rheumatology|2020|998

|Cell|2020|899

|Nature Communications|2020|846

Related Papers